- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01758003
Physical Activity in Healthy Over 40s
Patterns of Physical Activity in a Healthy Population Aged Over 40 Years Old
The primary aim of this research is to examine physical activity in a healthy population aged over 40 years old.
Subsidiary aims of this research are:
- To establish normative values for physical activity levels, exercise capacity, quality of life and readiness to change physical activity behaviour (stages of change, self-efficacy, decisional balance and processes of change) in a healthy population age-matched to a population with bronchiectasis.
- To explore physical activity levels, exercise capacity and quality of life in a healthy population age-matched to a population with bronchiectasis.
- To explore readiness to change physical activity behaviour (stages of change, self-efficacy, processes of change and decisional balance) in a healthy population compared to a population with bronchiectasis.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
The current study is running alongside an externally funded project measuring physical activity levels in patients with bronchiectasis (ClinicalTrials.gov ID: NCT01569009). In order to more fully understand physical activity behaviours in bronchiectasis, it is important to compare the patterns of physical activity, exercise capacity and quality of life of the patients with bronchiectasis to a healthy age-matched population.
For a healthy population of similar age to patients with bronchiectasis, little applicable research currently exists with regard to normative values of physical activity and sedentary behaviour. In this particular study, we will measure physical activity levels in healthy individuals age-matched to patients with bronchiectasis. The most commonly used questionnaire to assess physical activity is the International Physical Activity Questionnaire. Pedometers are inexpensive devices which can be used to assess daily step count and time spent in walking. Activity monitors are more expensive and require technical expertise for analysis and interpretation. However, they provide more in-depth information on pattern, quantity and intensity of activity including daily sedentary time. In this study, the investigators will use the ActiGraph activity monitor, ActivPAL activity monitor, DigiWalker pedometer and IPAQ to measure the physical activity levels in healthy individuals age-matched to patients with bronchiectasis. This study will not focus on participants who engage in high levels of physical activity as they are unlikely to represent the physical activity levels of patients with bronchiectasis.
This study will include the Modified Shuttle Test. Exercise capacity measured by the Modified Shuttle Test is normally only utilized in respiratory disease populations such as patients with cystic fibrosis. However, it has recently been highlighted that there is a need for reference data in healthy populations. This study will also use the EQ-5D-5L questionnaire to assess quality of life. Preliminary testing of the EQ-5D-5L questionnaire, an update to the well-researched EQ-5D-3L, has only recently been conducted. There is a need for studies to provide more normative data on the EQ-5D-5L.
This study will also assess readiness to change physical activity behaviour in a healthy population utilising transtheoretical model components such as stages of change, self-efficacy, decisional balance and processes of change; which have all been shown to be important in physical activity behaviour. Understanding healthy individuals' perspectives on readiness to change physical activity behaviour and the links between important outcomes will help to inform future physical activity interventions.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Antrim
-
Jordanstown, Antrim, Det Forenede Kongerige, BT37 0QB
- University of Ulster
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- aged ≥ 40 years
- does not participate in regular exercise or participates in regular exercise at a moderate level ≤ 3 hours/week
- ≤ 10 pack-year history of smoking
- does not suffer from any concomitant condition which may prevent participation in physical activity
- answered 'No' to all questions in the Medical Questionnaire
Exclusion Criteria:
- participates in regular exercise at a moderate level > 3 hours/week
- pregnancy
- any concomitant condition which may prevent participation in physical activity
- answered 'Yes' to any questions in the Medical Questionnaire
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Step counts measured by the ActiGraph GT3X+ activity monitor
Tidsramme: Seven days
|
Participants will wear the ActiGraph GT3X+ activity monitor for seven consecutive full days between Visit 1 (Day 0) and Visit 2 (Day 8).
|
Seven days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Træningskapacitet ved hjælp af Modified Shuttle Test
Tidsramme: Dag 8
|
Deltagerne vil gennemføre den modificerede shuttletest ved besøg 2 (dag 8).
|
Dag 8
|
Stage of Change i form af fysisk aktivitet ved hjælp af Stages of Change-spørgeskemaet
Tidsramme: Dag 8
|
Deltagerne vil udfylde spørgeskemaet om stadier af forandring ved besøg 2 (dag 8).
The Stages of Change Questionnaire er den tidsmæssige del af den transteoretiske model.
Det vil blive brugt til at bestemme det aktuelle ændringsstadium, deltageren befinder sig på med hensyn til deres fysiske aktivitetsadfærd.
|
Dag 8
|
Step counts measured by the ActivPAL activity monitor
Tidsramme: Seven days
|
Participants will wear the ActivPAL activity monitor for seven consecutive full days between Visit 1 (Day 0) and Visit 2 (Day 8).
|
Seven days
|
Number of steps measured by the Yamax CW-700 DigiWalker pedometer
Tidsramme: Seven days
|
Participants will wear the Yamax CW-700 DigiWalker pedometer for seven consecutive full days between Visit 1 (Day 0) and Visit 2 (Day 8).
|
Seven days
|
Physical activity levels and sitting time using the International Physical Activity Questionnaire
Tidsramme: Day 8
|
Participants will complete the International Physical Activity Questionnaire at Visit 2 (Day 8).
It will be used to measure participants' time spent in physical activity in the last seven days and also to provide self-reported sitting time.
|
Day 8
|
Quality of Life using the EuroQOL-5D-5L
Tidsramme: Day 8
|
Participants will complete the EuroQOL-5D-5L at Visit 2 (Day 8).
|
Day 8
|
Confidence to undertake physical activity using Marcus's Self-Efficacy Questionnaire
Tidsramme: Day 8
|
Participants will complete Marcus's Self-Efficacy Questionnaire at Visit 2 (Day 8).
Marcus's Self-Efficacy Questionnaire is a component of the transtheoretical model.
It will provide more detailed information on each individual's confidence to undertake physical activity in different situations.
|
Day 8
|
Perception of the benefits and negative aspects of physical activity using Marcus's Decisional Balance Questionnaire
Tidsramme: Day 8
|
Participants will complete Marcus's Decisional Balance Questionnaire at Visit 2 (Day 8).
Marcus's Decisional Balance Questionnaire is a component of the transtheoretical model.
It will assess each individual's perceptions of the benefits and negative aspects of physical activity.
|
Day 8
|
Strategies used to progress through the different stages of change using Marcus's Processes of Change Questionnaire
Tidsramme: Day 8
|
Participants will complete Marcus's Processes of Change Questionnaire at Visit 2 (Day 8).
Marcus's Processes of Change Questionnaire is a component of the transtheoretical model.
It describes the strategies and techniques individuals use to progress through the different stages of change.
|
Day 8
|
Perception of the feasibility and acceptability of the physical activity outcome measures
Tidsramme: Day 8
|
The researcher and the participants will answer the feasibility and acceptability questions at Visit 2 (Day 8).
The feasibility and acceptibility questions were designed for this study to assess the researchers' and participants' perspectives of the feasibility and acceptability of the physical activity outcome measures (ActiGraph, ActivPAL, pedometer and International Physical Activity Questionnaire.
|
Day 8
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Judy Bradley, PhD, University of Ulster
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 12/08
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Fysisk aktivitet
-
University of ValenciaAktiv, ikke rekrutterendeAutismespektrumforstyrrelse | Attention Deficit Hyper ActivitySpanien
-
NYU Langone HealthAfsluttetAttention Deficit Hyper ActivityForenede Stater
-
Texas Woman's UniversityAfsluttetIntellektuel handicap | Autismespektrumforstyrrelse | Motoriske lidelser | Motorforsinkelse | Sanseforstyrrelser | Attention Deficit Hyper Activity
-
Cingulate TherapeuticsPremier Research Group plcAktiv, ikke rekrutterendeADHD | Attention Deficit Hyperactivity Disorder | ADHD - kombineret type | Attention Deficit Hyperactivity Disorder kombineret | Attention Deficit Hyper Activity | Opmærksomhedsunderskud hyperaktivitetForenede Stater
-
Cingulate TherapeuticsRekrutteringADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder med hyperaktivitet | ADHD - kombineret type | Attention Deficit Hyperactivity Disorder kombineret | Attention Deficit Hyper Activity | Opmærksomhedsunderskud hyperaktivitetForenede Stater
-
Affiliated Hospital to Academy of Military Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking...RekrutteringAldersinterval ≥16 år, køn ubegrænset | Histopatologi bekræftet diffust stort B-celle lymfom eller højgradigt B-celle lymfom | Modtaget tidligere førstelinjekemoterapi for DLBCL eller HGBL, kunne ikke nå CR i fire cyklusser eller tilbagefald | Mindst én positiv læsion ifølge 2014 Lugano-kriterierne... og andre forholdKina